16 years ago, Alexander Bragilevsky received a devastating diagnosis of melanoma. He immediately underwent treatment in Russia, but the results were not encouraging. At a certain point, the doctors lost hope, discontinued Alexander’s treatment and left him with a prescription for strong painkillers.

In 2013, Pedro da Silva received intensive chemotherapy treatment for testicular cancer. In 2016, he was diagnosed with leukemia.

According to all the doctors’ prognoses, Tamir Gilat should not be alive right now. After he was diagnosed with cancer in 2011, he was given three months to live.

Prof. Dan Aderka, Head of the Gastrointestinal Cancer Service at Sheba, recently conducted research that brought an end to a long-standing controversy over the treatment regimen for Colorectal Cancer (CRC) patients. The study discovered that various combinations of chemotherapy and biological medicine directly affected the life expectancy of CRC patients, depending on the specific type of tumor.

KidneyCure, the Israeli cell therapy company based in Tel Aviv, is developing treatment for end-stage renal disease. This innovative company recently announced the financial support of new investors, Aurum Ventures, controlled by Morris Kahn, and Direct Insurance –Financial Investments. Altogether, the addition of these two investors brings the total capital raised by KidneyCure to $4 million.

In recent years, researchers around the world have shown that the gut bacteria of cancer patients may yield essential information for improving the efficacy of cancer therapies. These findings appear to be linked with the capability of gut bacteria, also known as the gut microbiome, to boost the immune system.

Chest pain is one of the most obvious heart attack symptoms. However, chest pain can also be a sign of less serious medical problems. This is why rapid discernment of chest pain is so critical.

In a first in Israel, Sheba Medical Center has achieved remission in a pediatric patient’s leukemia through CAR T-cell therapy. This innovative therapy is still only in clinical trials in the US, but has shown excellent results in over 70% of patients. Sheba is proud to be able to offer this effective treatment to our patients.

Last month, a celebratory atmosphere filled the halls of the Edmond and Lily Safra Children’s Hospital at Sheba. The occasion marked a significant milestone in the medical journey of 9-year-old Alexandra Opoku. After bravely enduring a challenging battle with cancer spanning nearly three years, she successfully completed her treatment and has been cleared for discharge. […]